Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Month: July 2025

92-OR: Evaluating Intact Proinsulin, Des-31,32 Proinsulin, and Des-64,65 Proinsulin as Potential Biomarkers of Type 1 Diabetes

July 1, 2025 by sugaradmin

Introduction and Objective: Persistent proinsulin secretion and elevated proinsulin-to-C-peptide ratios have been reported in T1D. However, the potential of individual proinsulin proteoforms as biomarkers in T1D has not been evaluated due to the challenges associated with assay specificity. Herein, we present the first assessment of intact proinsulin, des-31,32 proinsulin, and des-64,65 proinsulin using a newly […]

Read More
DiabetesLeave a Comment on 92-OR: Evaluating Intact Proinsulin, Des-31,32 Proinsulin, and Des-64,65 Proinsulin as Potential Biomarkers of Type 1 Diabetes

789-P: The Use of Antiobesity Medications and the Increased Risk of Alopecia—A Meta-analysis of Randomized Controlled Trials

July 1, 2025 by sugaradmin

Introduction and Objective: Alopecia is a potential adverse event of anti-obesity medications (AOMs). Rapid weight loss may result in deficiencies of key nutrients and act as a physiological stressor, potentially disrupting hair growth cycles and increasing hair shedding. This study aimed to evaluate the association between AOMs and risk of alopecia.Methods: PubMed, EMBASE, Cochrane Library, […]

Read More
DiabetesLeave a Comment on 789-P: The Use of Antiobesity Medications and the Increased Risk of Alopecia—A Meta-analysis of Randomized Controlled Trials

750-P: ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose Study

July 1, 2025 by sugaradmin

Introduction and Objective: ASC30 is an oral GLP-1R biased small molecule agonist without β-arrestin recruitment, discovered and developed in-house at Ascletis. ASC30 has unique and differentiated properties that enable the administration of one small molecule as both a once-monthly subcutaneous injection and a once-daily oral tablet. The current study assessed safety, tolerability and pharmacokinetics of […]

Read More
DiabetesLeave a Comment on 750-P: ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose Study

929-P: Assessment of Impact of Online CME and Future Education Needs Related to Automated Insulin Delivery Use in People with T2D

July 1, 2025 by sugaradmin

Introduction and Objective: We measured the impact of online continuing medical education (CME) on knowledge and confidence of primary care physicians (PCPs) and diabetologists/endocrinologists (D/Es) on new data for using automated insulin delivery (AID) in people with T2D.Methods: The intervention comprised a 30-min online video-based discussion among 3 expert faculty with downloadable slides. Education effect […]

Read More
DiabetesLeave a Comment on 929-P: Assessment of Impact of Online CME and Future Education Needs Related to Automated Insulin Delivery Use in People with T2D

1936-LB: Sharing a Night Shift—Couples Managing Type 1 Diabetes

July 1, 2025 by sugaradmin

Introduction and Objective: Persons with type 1 diabetes (PWD) often experience nighttime fluctuations in blood glucose levels, which require active management. Those who sleep with a partner may receive instrumental support in diabetes management tasks. We examined whether partner nighttime awakenings that coincided with PWD awakenings predicted better blood glucose management following excursions.Methods: Eight emerging […]

Read More
DiabetesLeave a Comment on 1936-LB: Sharing a Night Shift—Couples Managing Type 1 Diabetes

388-P: Keap1-Nrf2 Modulation and SLC7A11 Restoration—Bardoxolone Methyl as a Ferroptosis Inhibitor in Renal Tubular Epithelial Cells

July 1, 2025 by sugaradmin

Introduction and Objective: Ferroptosis of renal tubular epithelial cells (RTECs) is implicated in the pathogenesis of diabetic kidney disease (DKD). Bardoxolone methyl (BM), a synthetic triterpenoid with antioxidant and anti-inflammatory properties, has shown promise in clinical trials for preventing DKD-related renal decline but carries a risk of heart failure. Recent studies revealed that 2-deoxy-D-ribose (dRib) […]

Read More
DiabetesLeave a Comment on 388-P: Keap1-Nrf2 Modulation and SLC7A11 Restoration—Bardoxolone Methyl as a Ferroptosis Inhibitor in Renal Tubular Epithelial Cells

825-P: AI-Based Optimization of Patient Eligibility for Oral Insulin Treatment—A Post Hoc Analysis to Identify Responders

July 1, 2025 by sugaradmin

Introduction and Objective: In a Phase III, randomized, placebo-controlled, multi-center study in which T2DM patients were treated with oral insulin for 26 weeks, the primary endpoint defined as a decrement of 0.6% HbA1c by end of treatment was not met. A post-hoc analysis aimed to identify subpopulations with substantial clinical responses to treatment.Methods: Explainable AI […]

Read More
DiabetesLeave a Comment on 825-P: AI-Based Optimization of Patient Eligibility for Oral Insulin Treatment—A Post Hoc Analysis to Identify Responders

114-OR: The Mammalian Adipose Tissue Knowledge Portal (MATKP)—An Open-Access Web Resource Providing Data and Knowledge Related to Mammalian Adipose Tissue

July 1, 2025 by sugaradmin

Introduction and Objective: Diabetes and adipose research generate rich datasets whose accessibility and integration are often limited. To address this challenge, we created the Mammalian Adipose Tissue Knowledge Portal (MATKP; matkp.org), an open community portal for multi-species mammalian adipose biology. MATKP is accessible to diverse users and aggregates data for adipose tissues and cell types, […]

Read More
DiabetesLeave a Comment on 114-OR: The Mammalian Adipose Tissue Knowledge Portal (MATKP)—An Open-Access Web Resource Providing Data and Knowledge Related to Mammalian Adipose Tissue

928-P: AI-Based Fully Closed Loop (FCL) Achieves Improved Glycemia vs. Hybrid Closed Loop (HCL) in People with Type 1 Diabetes (T1D)

July 1, 2025 by sugaradmin

Introduction and Objective: HCL is the preferred insulin delivery method for people with T1D, however mealtime carbohydrate counting limits benefit. Use of AI to implement automated insulin delivery (AID) algorithms, able to avoid mealtime interactions, could alleviate burden and broaden use. We tested the latest UVA AID neural network-based system (AIDANET) in FCL in a […]

Read More
DiabetesLeave a Comment on 928-P: AI-Based Fully Closed Loop (FCL) Achieves Improved Glycemia vs. Hybrid Closed Loop (HCL) in People with Type 1 Diabetes (T1D)

535-P: Objectively and Subjectively Measured Physical Activity in Chinese Immigrants with Type 2 Diabetes in New York City

July 1, 2025 by sugaradmin

Introduction and Objective: There is a paucity of objectively measured physical activity (PA) data in underserved populations. We examined objectively measured and self-reported PA among Chinese immigrants with type 2 diabetes (T2D) in NYC.Methods: We analyzed baseline data from 60 participants. PA was measured by a wrist-worn ActiGraph GT9X accelerometer and the International Physical Activity […]

Read More
DiabetesLeave a Comment on 535-P: Objectively and Subjectively Measured Physical Activity in Chinese Immigrants with Type 2 Diabetes in New York City

Posts navigation

Newer posts

Recent Posts

  • Olympic Track and Field Star Allyson Felix Talks Rest and Recovery
  • Fructose in Ultra-Processed Foods May Raise Metabolic Disease
  • Trump Reclassifies Marijuana as Less Dangerous in Major Policy Shift
  • Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62%
  • FDA Issues Nationwide Recall of ‘Extended Release’ Xanax for Anxiety

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness